| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate |
1991-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c89f7e4835bf360cea8e18da25f92468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fae34db4f2b06c7b808c962d7643b4b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c889ab3ccb98332acdc4263a4d170c37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78c8f27aac87380d56eee099f7d86089
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac34b6017ff7cd0bdafbee6ff98e2031 |
| publicationDate |
1992-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9211012-A1 |
| titleOfInvention |
Use of quisqualate-receptor antagonists for treating parkinson's disease |
| abstract |
Described is a new use of antagonists of the AMPA receptor complex and their physiologically compatible salts for the preparation of a drug for the prevention and treatment of Parkinson's disease. Also described are pharmaceutical preparations containing these compounds and synergistically active combinations of them with conventional anti-Parkinson's-disease preparations. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6251903-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6147075-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5620979-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5514680-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011076946-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5622952-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0647137-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922715-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9835948-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943586-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5631373-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5977107-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2338492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0647137-A4 |
| priorityDate |
1990-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |